Sniper Therapeutics wins Venture Challenge Fall 2024!
December 13, 2024
The winner of the Venture Challenge was announced today at the Dutch Life Sciences Conference. The proud winner of the 2024 fall edition is Sniper Therapeutics! The innovative venture is developing a new T-cell based therapy for Diffuse Midline Glioma (DMG), which is an aggressive and incurable pediatric brain tumor.